早产和胎膜早破 (PROM) 检测市场 - 2026-2031 年预测

预计早产和胎膜早破 (PROM) 检测市场将从 2025 年的 17.48 亿美元成长到 2031 年的 25.21 亿美元，复合年增长率为 6.3%。

受全球早产和胎膜早破（PROM）病例数量不断增加的推动，早产和胎膜早破（PROM）检测市场需求日益增长。这些诊断工具能够在早期发现孕妇胎膜破裂，从而及时干预，减少併发症，并有可能预防早产。

主要成长要素是由于不健康的生活方式和压力等因素导致早产发生率上升。此外，青少年怀孕率的上升以及孕妇妊娠毒血症病例的增加也预计将对市场扩张产生正面影响。妊娠毒血症併发症每年都会显着增加孕产妇和胎儿的死亡风险，而青少年母亲早产及相关新生儿疾病的风险更高。

早产带来的不良健康后果凸显了早期发现的必要性。早产儿容易出现许多短期和长期併发症，包括呼吸窘迫症候群、心血管疾病、颅内出血、坏死性小肠结肠炎、贫血、黄疸、低血糖、脑性麻痹、发育迟缓、感染疾病和气喘等慢性疾病。

政府措施和正在进行的临床研究计划正在推动市场发展。世界卫生组织等机构正在进行研究，以改善中低收入国家孕妇和早产儿的护理，包括产前皮质类固醇、营养管理和袋鼠即时护理等方面的试验。国际妇产科联合会等合作组织正在为早产儿的管理提供良好实践建议。

从区域来看，由于技术进步、意识提高以及Hologic、Abbott Laboratories和Sera Prognostics Inc.等主要企业的存在，北美预计将占据主要市场份额，并在预测期内实现显着增长，这些参与者正在推动更多机会和创新。

该领域的主要企业包括Hologic公司，这是一家专注于女性健康的跨国公司。该公司提供周产期检测解决方案，例如用于评估早产风险的Rapid fFN®检测，以及QuikCheck fFN®和Rapid fFN® 10Q Cassette Kit等试剂盒。 2023年2月，另一家知名的女性健康相关企业Sera Prognostics Inc.宣布了在ChristianaCare进行的AVERT早产试验的积极初步结果，该试验表明新生儿发病率和死亡率有所降低。

这些临床、人口统计和支持性因素正在推动市场整体快速扩张，透过提高诊断能力来满足母胎医学的关键需求。

本报告的主要优势：

• 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略进入市场的可能性。
• 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
• 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2021年至2025年的实际数据和2026年至2031年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区（包括国家）分類的收入和预测评估
• 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

5. 早产和胎膜早破 (PROM) 检测市场（按早产检测机构划分）

• 介绍
• 骨盆腔检查
• 超音波
• 其他的

6. 早产和胎膜早破 (PROM) 检测市场（按 PROM 检测划分）

• 介绍
• 硝嗪试验
• 蕨状结晶试验
• 其他的

7. 按最终用户分類的早产和胎膜早破 (PROM) 检测市场

• 介绍
• 诊断检查室
• 医院
• 其他的

8. 各地区早产及胎膜早破 (PROM) 检测市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第十章：公司简介

• Hologic, Inc
• Abbott
• Sera Prognostics Inc.
• CooperSurgical Inc.
• IQ Products
• Qiagen NV
• BHR Pharmaceuticals
• NX Prenatal, Inc.

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

The preterm birth and PROM testing market, with a 6.3% CAGR, is expected to grow to USD 2.521 billion in 2031 from USD 1.748 billion in 2025.

The preterm birth and PROM testing market is experiencing rising demand driven by increasing global cases of preterm births and premature rupture of membranes (PROM). These diagnostic tools enable early detection of fetal membrane rupture in pregnant women, facilitating timely interventions to mitigate complications and potentially prevent preterm delivery.

Key growth drivers include escalating preterm birth incidences influenced by factors such as unhealthy lifestyles and stress. Additionally, rising adolescent pregnancies and preeclampsia cases among pregnant women are expected to positively influence market expansion. Preeclampsia complications contribute to significant maternal and fetal mortality annually, while adolescent mothers face elevated risks of preterm delivery and associated neonatal conditions.

The adverse health effects of preterm birth underscore the need for early detection. Preterm births are associated with numerous short- and long-term complications, including respiratory distress, cardiovascular issues, intracranial hemorrhage, necrotizing enterocolitis, anemia, jaundice, hypoglycemia, cerebral palsy, developmental delays, and chronic conditions such as infections and asthma.

Government initiatives and ongoing clinical research projects support market advancement. Organizations like the WHO conduct studies in low- and middle-income countries to enhance care for pregnant women and preterm infants, including trials on antenatal corticosteroids, nutritional management, and immediate kangaroo mother care. Collaborative efforts, such as those from the International Federation of Gynecology and Obstetrics, provide good practice recommendations for preterm birth management.

Geographically, North America is poised for significant growth, holding a substantial market share during the forecast period. Contributing factors include technological advancements, heightened awareness, and the presence of major industry players such as Hologic, Abbott Laboratories, and Sera Prognostics Inc., which enhance accessibility and innovation.

Leading companies in the sector include Hologic Inc., a multinational focused on women's health, offering perinatal testing solutions like the Rapid fFN(R) test to assess preterm birth risk, along with kits such as QuikCheck fFN(R) and Rapid fFN(R) 10Q Cassette Kit. Sera Prognostics Inc., a prominent women's health company, reported positive top-line results in February 2023 from the AVERT Preterm Trial, demonstrating reductions in neonatal morbidity or death when conducted at ChristianaCare.

Overall, the market is expanding rapidly due to these clinical, demographic, and supportive factors, addressing critical needs in maternal-fetal medicine through improved diagnostic capabilities.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Preterm Birth and PROM Testing Market Segmentation

• By Preterm Birth Tests
• Pelvic Exam
• Ultrasound
• Others
• By PROM Tests
• Nitrazine Test
• Ferning Test
• Others
• By End-User
• Diagnostic Laboratories
• Hospitals
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PRETERM BIRTH AND PROM TESTING MARKET BY PRETERM BIRTH TESTS

• 5.1. Introduction
• 5.2. Pelvic exam
• 5.3. Ultrasound
• 5.4. Others

6. PRETERM BIRTH AND PROM TESTING MARKET BY PROM TESTS

• 6.1. Introduction
• 6.2. Nitrazine Test
• 6.3. Ferning Test
• 6.4. Others

7. PRETERM BIRTH AND PROM TESTING MARKET BY END-USER

• 7.1. Introduction
• 7.2. Diagnostic Laboratories
• 7.3. Hospitals
• 7.4. Others

8. PRETERM BIRTH AND PROM TESTING MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Hologic, Inc
• 10.2. Abbott
• 10.3. Sera Prognostics Inc.
• 10.4. CooperSurgical Inc.
• 10.5. IQ Products
• 10.6. Qiagen N.V.
• 10.7. BHR Pharmaceuticals
• 10.8. NX Prenatal, Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations